Rare Genetic Variants and Autism Spectrum Disorders - Oxford Medicine

Subscriber Login

Forgotten your password?

Don't have an account? Recommend Oxford Medicine Online to your institution or view a list of titles available for individual purchase.

Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Rare Genetic Variants and Autism Spectrum Disorders 

Rare Genetic Variants and Autism Spectrum Disorders

Chapter:
Rare Genetic Variants and Autism Spectrum Disorders
Author(s):

Hande Kaymakçalan

and Matthew W. State

DOI:
10.1093/med/9780195371826.003.0047
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 25 September 2016

This chapter discusses the contribution of rare and very rare genetic variation to autism spectrum disorders (ASD). The first section provides a basic background into the nature of genetic variation and distinctions between common and rare alleles. The second describes two competing, but not necessarily mutually exclusive, hypotheses about the genomic underpinnings of ASD, the common-variant: common-disease hypothesis and the rare-variant: common-disease hypothesis. The section third addresses the so-called “outlier strategy” of gene discovery, in which the focus is on rare and very rare alleles irrespective of their overall contribution to population risk. The fourth addresses the emerging evidence regarding the cumulative contribution of rare variation to ASD, including a consideration of opportunities and challenges facing current efforts to tackle this question. Finally, the chapter considers recent rare variant discoveries that have raised the prospect that a given specific genetic mutation may contribute to a broad spectrum of neuropsychiatric and neurodevelopmental outcomes ranging from ASD to mental retardation, seizure, and schizophrenia.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.